Table 2.
Data collection at baseline and post-discharge assessment timepoints
| Point of discharge | Post-discharge | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Baseline | 2–3 days | 5–7 days | Week 2 | Week 3 | Week 4 | Week 5 | Week 6 | Week 7 | Week 8 | Post-study | End of study interviews | |
| Screening log completion (Centre 1 only) | ✓ | |||||||||||
| Participant demographic and clinical characteristics | ✓ | |||||||||||
| ePRO questionnaire completion | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
| FACT-G & EQ-5D questionnairesa | ✓ | ✓ | ✓ | |||||||||
| Weekly follow-up participant interviews | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ||
| Health resource use questionnaireb | ✓ | |||||||||||
| End of study participant interviews (10% participants) | ✓ | |||||||||||
| Weekly follow-up clinician interviews (Centre 1 only) | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | |||
| End of study clinician interviews (Centre 1 only) | ✓ | |||||||||||
Abbreviations: ePRO electronic patient-reported outcome, FACT-G Functional Assessment in Cancer Therapy Scale – General
aThe FACT-G is a standardised cancer specific health related quality of life measure. The EQ-5D is a standardised measure of health status used in clinical and economic evaluation. These measures were administered in paper format
bThe health resource use questionnaire included items to record use of prescription and non-prescription medication and other costs associated with patients’ recovery from surgery. These measures were administered in paper format